Bruker's Mass Spec Demo facility: Ensuring safe operation in COVID-19 and beyondVideo
This video showcases Bruker's Mass Spec Demo facility and how they are keeping employees safe and in operation during COVID-19 and beyond.
Cubis® II Modular Precision-, Analytical- and MicrobalancesVideo
For scientists in R&D and analytical laboratories needing the most reliable lab weighing results, the Cubis® II from Sartorius is a completely configurable, high performance portfolio of balance hardware and software that will align with your unique demands and compliance requirements to maximize operational efficiency and experimental outcomes.
Today our host Jen Fournier is in the lab with the dirtiest, grimiest samples. She knows if she tries to run them on LC-MS as-is, she’d degrade the column, get low sensitivity … and have to clean the mass spectrometer. Is there a better way to start with clean samples?Watch Now
Automated LC-MSMS methods for Clinical Diagnostics - Realized for therapeutic drug monitoring and viVideo
Tecan and RECIPE have worked together to automate ClinMass® LC-MSMS Complete Kits for the analysis of vitamin D and immunosuppressants on a Freedom EVO® platform, to help meet the demand for high throughput sample preparation for mass spectrometry in clinical labs.Watch Now
Listen as Prof Neil Kelleher, discusses how he believes the Orbitrap Fusion Lumos MS might better characterize unexpected PTMs in Top-Down Proteomics to decode cellular function.Watch Now
The proteome is the most functional component encoded for in the genome. Advances in proteomic technologies allow comprehensive profiling of of signaling pathways, precise expression of therapeutic targets in tissues and cellular subcompartments, and of metabolomic features that determine likelihood of therapeutic response. Moreover the current paradigm shift in cancer therapy with dramatic and durable responses to antibody and checkpoint therapeutics that trascend tumor genomic profiles further emphasize opportunities to identify novel targets and tailor treatment based on their expression patterns. The potential for personalizing cancer treatment based on proteomic and metabolomic profiles will be presented for epithelial type tumors including lung and pancreatic cancer.Watch Now
CRISPR is revolutionizing the life sciences. Genome editing using RNA-programmable nucleases opens up a wealth of experimental options. At the same time, it makes creating new cell and animal models faster, easier and cheaper than in the past. Consequently, researchers in areas as diverse as cell/developmental biology, genetics or clinical research are turning to CRISPR as their method of choice.Watch Now